Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02484547
Brief Title: 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)

First Submitted : June 18, 2015
First Submitted that Met QC Criteria : June 26, 2015
First Posted : June 29, 2015 (Estimate)

Certification/Extension First Submitted : August 4, 2020
Certification/Extension First Submitted that Met QC Criteria : August 4, 2020
Certification/Extension First Posted : August 5, 2020

Last Update Submitted that Met QC Criteria : May 5, 2021
Last Update Posted : May 6, 2021